GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) » Definitions » Forward Dividend Yield %

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Forward Dividend Yield % : 0.00% (As of May. 24, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Harbin Gloria Pharmaceuticals Co Forward Dividend Yield %?

As of today (2024-05-24), the Forward Annual Dividend Yield of Harbin Gloria Pharmaceuticals Co is 0.00%.

As of today (2024-05-24), the Trailing Annual Dividend Yield of Harbin Gloria Pharmaceuticals Co is 0.00%.

SZSE:002437's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.855
* Ranked among companies with meaningful Forward Dividend Yield % only.

Harbin Gloria Pharmaceuticals Co's Dividends per Share for the three months ended in Mar. 2024 was ¥0.00.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Harbin Gloria Pharmaceuticals Co was 56.70% per year. The lowest was -47.50% per year. And the median was -23.10% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Harbin Gloria Pharmaceuticals Co's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Harbin Gloria Pharmaceuticals Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harbin Gloria Pharmaceuticals Co's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Harbin Gloria Pharmaceuticals Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Harbin Gloria Pharmaceuticals Co's Forward Dividend Yield % falls into.



Harbin Gloria Pharmaceuticals Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Harbin Gloria Pharmaceuticals Co  (SZSE:002437) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Harbin Gloria Pharmaceuticals Co Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Harbin Gloria Pharmaceuticals Co's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Harbin Gloria Pharmaceuticals Co (SZSE:002437) Business Description

Traded in Other Exchanges
N/A
Address
Beijing Road No 29, Harbin Economic and Technological Development Zone, Harbin, CHN, 150025
Harbin Gloria Pharmaceuticals Co Ltd is a tech biopharmaceutical enterprise. It is engaged in the research, development, production, and sale of pharmaceutical products primarily in China. The company offers cardiovascular drugs; cardiac cerebrovascular medication; vitamins and minerals; urinary tract drugs; urinary system medication; anti-tumor medication; endocrine system drugs; anti-infective drugs; digestive system medication; respiratory medication; and other medications.

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Headlines

No Headlines